Lexaria Bioscience Corp. (LEXX): auditor change — Lexaria Bioscience replaces auditor; Davidson declines re-election, MaloneBailey appointed

Lexaria Bioscience Corp.

Davidson & Company LLP will not stand for re-election after completing FY2022 audit.
No disagreements or reportable events with Davidson during FY2022 and FY2021.
Audit Committee selected MaloneBailey LLP as new independent auditor effective Nov 25, 2022.
No prior consultations with MaloneBailey regarding accounting principles or audit opinions.

item 4.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Lexaria Bioscience Corp. engaged MaloneBailey LLP as its auditor.

Action: engagement
Auditor: MaloneBailey LLP

Exact text from the filing

the Board of Directors accepted this recommendation and approved the appointment of MaloneBailey effective as of November 25, 2022.

View on SEC.gov

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Davidson & Company LLP resigned as auditor of Lexaria Bioscience Corp..

Action: resignation
Auditor: Davidson & Company LLP
Successor: MaloneBailey LLP

Exact text from the filing

Davidson & Company LLP (“Davidson & Co.”), advised Lexaria Bioscience Corp. (the “Registrant”) that it would not stand for re-election as the Registrant’s Certifying Accountant after completing its audit of the Registrant’s year end financial statements.

View on SEC.gov

4 auditor changes filed in the last 30 days. Browse all auditor changes →

Lexaria Bioscience Corp. filing history →

Source: SEC EDGAR

accession 0001640334-22-002518

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.